Immunocore Holdings plc (IMCR)
NASDAQ: IMCR · Real-Time Price · USD
28.33
-0.10 (-0.33%)
Dec 20, 2024, 4:00 PM EST - Market closed
Immunocore Holdings Stock Forecast
Stock Price Forecast
The 11 analysts with 12-month price forecasts for Immunocore Holdings stock have an average target of 65.18, with a low estimate of 24 and a high estimate of 100. The average target predicts an increase of 130.11% from the current stock price of 28.33.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for IMCR stock from 13 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 4 | 4 | 3 | 2 | 2 |
| Buy | 7 | 7 | 7 | 8 | 7 | 6 |
| Hold | 1 | 1 | 1 | 2 | 3 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 1 | 1 | 1 |
| Total | 13 | 12 | 12 | 14 | 13 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Buy → Hold Downgrades $74 → $35 | Buy → Hold | Downgrades | $74 → $35 | +23.57% | Dec 13, 2024 |
| Mizuho | Mizuho | Buy → Hold Downgrades $72 → $38 | Buy → Hold | Downgrades | $72 → $38 | +34.16% | Nov 11, 2024 |
| Needham | Needham | Strong Buy Maintains $78 → $71 | Strong Buy | Maintains | $78 → $71 | +150.66% | Nov 7, 2024 |
| UBS | UBS | Strong Sell Initiates $24 | Strong Sell | Initiates | $24 | -15.27% | Oct 24, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $100 | Strong Buy | Reiterates | $100 | +253.05% | Oct 24, 2024 |
Financial Forecast
Revenue This Year
322.24M
from 249.43M
Increased by 29.19%
Revenue Next Year
362.71M
from 322.24M
Increased by 12.56%
EPS This Year
-0.85
from -1.13
EPS Next Year
-1.56
from -0.85
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 419.2M | 479.1M | 526.1M | |||
| Avg | 322.2M | 362.7M | 390.6M | |||
| Low | 301.8M | 318.3M | 340.5M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 68.0% | 48.7% | 45.0% | |||
| Avg | 29.2% | 12.6% | 7.7% | |||
| Low | 21.0% | -1.2% | -6.1% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -0.48 | -0.22 | -0.61 | |||
| Avg | -0.85 | -1.56 | -2.17 | |||
| Low | -1.45 | -2.54 | -3.80 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.